Cromwell Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Buy
1,078
+297
+38% +$143K 0.24% 72
2026
Q1
$384K Sell
781
-22
-3% -$11.9K 0.22% 91
2025
Q4
$466K Hold
803
0.25% 73
2025
Q3
$390K Buy
803
+580
+260% +$270K 0.21% 88
2025
Q2
$90.7K Sell
223
-877
-80% -$367K 0.06% 321
2025
Q1
$548K Buy
1,100
+261
+31% +$141K 0.35% 48
2024
Q4
$437K Buy
839
+93
+12% +$51.1K 0.25% 69
2024
Q3
$462K Buy
746
+8
+1% +$4.74K 0.3% 67
2024
Q2
$408K Buy
+738
New +$423K 0.24% 76

Other funds holding TMO

Cromwell Holdings's TMO Position: Q2 2026 in Review

Cromwell Holdings increased its Thermo Fisher Scientific (TMO) stake by 38% in Q2 2026, buying an estimated $143K and bringing the position to 1,078 shares worth $541K. The position accounts for 0.24% of the portfolio, ranked #72.

Cromwell Holdings first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $548K in Q1 2025. 446 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cromwell Holdings held 1,078 shares of Thermo Fisher Scientific worth $541K as of Q2 2026.
  • Cromwell Holdings bought 297 Thermo Fisher Scientific shares in Q2 2026, an estimated $143K.
  • Thermo Fisher Scientific made up 0.24% of Cromwell Holdings's portfolio in Q2 2026, its #72 holding.
  • Cromwell Holdings first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Thermo Fisher Scientific position peaked at $548K in Q1 2025.
  • 446 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.